Zobrazeno 1 - 10
of 336
pro vyhledávání: '"M. Hitt"'
Autor:
Francisca Cristi, Maiah Walters, Nashae Narayan, Kate Agopsowicz, Mary M. Hitt, Maya Shmulevitz
Publikováno v:
Molecular Therapy: Oncology, Vol 32, Iss 2, Pp 200798- (2024)
Externí odkaz:
https://doaj.org/article/8aeb8f35758f4fb3b9c9fce5dc881027
Autor:
Brittany A. Umer, Ryan S. Noyce, Quinten Kieser, Nicole A. Favis, Mira M. Shenouda, Kim J. Rans, Jackie Middleton, Mary M. Hitt, David H. Evans
Publikováno v:
PLoS ONE, Vol 19, Iss 3 (2024)
Externí odkaz:
https://doaj.org/article/d5115fb703044ebb8c0818da67a442e7
Autor:
Francisca Cristi, Maiah Walters, Nashae Narayan, Kate Agopsowicz, Mary M. Hitt, Maya Shmulevitz
Publikováno v:
Molecular Therapy: Oncolytics, Vol 31, Iss , Pp 100743- (2023)
Wild-type reovirus serotype 3 Dearing (T3wt), a non-pathogenic intestinal virus, has shown promise as a cancer therapy in clinical trials, but it would benefit from an increased potency. Given that T3wt is naturally adapted to the intestinal environm
Externí odkaz:
https://doaj.org/article/c32249d4295346bf8021e45e3af5fb65
Autor:
Elizabeth Garcia, Ismat Luna, Kaya L. Persad, Kate Agopsowicz, David A. Jay, Frederick G. West, Mary M. Hitt, Sujata Persad
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Abstract Invasive breast cancer (BrCa) is predicted to affect 1 in 9 women in a lifetime;1 in 32 will die from this disease. The most aggressive forms of BrCa, basal-like/triple-negative phenotype (TNBC), are challenging to treat and result in higher
Externí odkaz:
https://doaj.org/article/5712e87cd26c44929d2ad6ce84bd8c96
Publikováno v:
BMC Pregnancy and Childbirth, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background Women’s attitudes towards obstetric forceps likely contribute to declining use and opportunities for residency training, but formal documentation of women’s attitudes towards obstetric forceps is currently limited. A clearer u
Externí odkaz:
https://doaj.org/article/8e4e89e10c414f32875166e2d65349de
Publikováno v:
Frontiers in Molecular Biosciences, Vol 9 (2022)
Oncolytic viruses (OVs) are a promising type of cancer therapy since they selectively replicate in tumor cells without damaging healthy cells. Many oncolytic viruses have progressed to human clinical trials, however, their performance as monotherapy
Externí odkaz:
https://doaj.org/article/36e59af438a449a7b072afe831362d08
Autor:
Judith C. Hugh, Lacey S.J. Haddon, John Maringa Githaka, Gilbert Bigras, Xiuying Hu, Brittney Madden, John Hanson, Zsolt Gabos, Nadia V. Giannakopoulos, Fleur Huang, Mary M. Hitt, Kirk J. McManus, David Olson, Kelly Dabbs, John R. Mackey
Publikováno v:
Heliyon, Vol 8, Iss 1, Pp e08666- (2022)
Estrogen is thought to cause proliferation of all estrogen receptor positive (ER+) breast cancers. Paradoxically, in the Women's Health Initiative Trial, estrogen-only hormone replacement therapy reduced the incidence and mortality of low grade, ER+,
Externí odkaz:
https://doaj.org/article/02a9a9bf2a5f4ecbada80d2d235591c4
Autor:
Kyle G Potts, Chad R Irwin, Nicole A Favis, Desmond B Pink, Krista M Vincent, John D Lewis, Ronald B Moore, Mary M Hitt, David H Evans
Publikováno v:
EMBO Molecular Medicine, Vol 9, Iss 5, Pp 638-654 (2017)
Abstract Bladder cancer has a recurrence rate of up to 80% and many patients require multiple treatments that often fail, eventually leading to disease progression. In particular, standard of care for high‐grade disease, Bacillus Calmette–Guérin
Externí odkaz:
https://doaj.org/article/7a25d246a5d84cfdbca40ab0fd93b132
Autor:
Travis J. Pashak, Olivia M. Nelson, Makiya D. Tunstull, Brianna H. Vanderstelt, David P. Nichols, James M. Hitt
Publikováno v:
Clinical Psychologist. 27:4-21
In this argumentative literature review, we advocate an existentially-informed clinical psychology. Many of today’s challenging societal issues would benefit from the lens of existentialism, and our field has seen an emergence of interest lately in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c255659cfe089c7a312df0065c3efb2
https://doi.org/10.1080/13284207.2022.2108695
https://doi.org/10.1080/13284207.2022.2108695
Publikováno v:
Cancer Letters. 526:168-179
Bladder cancers, and specifically urothelial carcinoma, have few effective treatment options, and tumors typically develop resistance against standard of care chemotherapies leading to significant mortality. The development of alternative therapies w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4cba6fcac7787eccd4670a670f3a63a
https://doi.org/10.1016/j.canlet.2021.11.028
https://doi.org/10.1016/j.canlet.2021.11.028